Faculty profile

Normand Blais

Back to faculty

ProfessorDepartment of MedicineUniversité de Montréal

Normand Blais

Professor

Department of Medicine

Université de Montréal

Montreal, Quebec, Canada

Supervision signals

Professors usually supervise graduate students in their department's programs.
31 publications in the last five years, latest in 2026.
Senior (last) author on 4 recent papers, a sign of leading a research group.

These signals come from public records, including federal and provincial funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

1,567

Citations

135

Collaborators

Publications by year

Counts cover the publications linked to this profile. Citations and the h-index appear when the source records them.

Profiles and links

University Profile

Search on Google Scholar

Search on ResearchGate

iDORCID OpenAlex

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Read how they describe their research on their Université de Montréal profile.

Latest papers

Targeting common EGFR mutations in non–small cell lung cancer: a review of global phase 3 trials of third-generation inhibitors
Journal of the National Cancer Institute · 2026
Neoadjuvant Chemotherapy-Immunotherapy in Non-Small Cell Lung Cancer: Can Positron Emission Tomography Scan Predict Complete Pathologic Response?
The Annals of thoracic surgery · 2026
Consensus recommendations on surveillance and survivorship for patients with unresectable/stage IV non-small cell lung cancer after completing Immunotherapy: a Delphi study by Canadian experts
Lung Cancer · 2026

All 83 publications

83 publications.

Targeting common EGFR mutations in non–small cell lung cancer: a review of global phase 3 trials of third-generation inhibitors

Melosky B, Juergens RA, Chu QSC, Cheema P, Snow S, Leighl NB, Blais N, Ionescu DN, McLeod D, Tsao M-S

Journal of the National Cancer Institute20265 citations

DOI: 10.1093/jnci/djag008

Neoadjuvant Chemotherapy-Immunotherapy in Non-Small Cell Lung Cancer: Can Positron Emission Tomography Scan Predict Complete Pathologic Response?

Seitlinger J, Salko O, Bulgarelli Maqueda L, Meng A, Têtu M, Desilets A, Owen S, Shieh B, Wong A, Ofiara L, Agulnik J, Fiset PO, Malo J, Blais N, Florescu M, Tehfe M, Ferraro P, Nasir B, Cools-Lartigue J, Najmeh S, Juneau D, Elkrief A, Ferri L, Routy B, Liberman M, Spicer JD

The Annals of thoracic surgery20265 citations

DOI: 10.1016/j.athoracsur.2025.09.051 PMID: 41167577

Consensus recommendations on surveillance and survivorship for patients with unresectable/stage IV non-small cell lung cancer after completing Immunotherapy: a Delphi study by Canadian experts

Ko JJ, Blais N, Brade A, Clelland C, Juergens R, Liu G, Navani V, Snow S, Wheatley-Price P, Melosky B

Lung Cancer2026

DOI: 10.1016/j.lungcan.2026.109455

Management of bleeding and invasive procedures in patients treated with anti–factor XI(a) anticoagulants: proposals from the French Working Group on Perioperative Haemostasis and French Society of Thrombosis and Haemostasis

Anne Godiér, Dominique Lasne, Anne‐Céline Martin, Gilles Pernod, Pierre Albaladejo, Emmanuel de Maistre, Pierre Fontana, Thomas Lecompte, Grégoire Le Gal, Jerrold H. Levy, Mikaël Mazighi, François Mullier, Philippe Nguyên, Stéphanie Roullet, Jean‐François Schved, Piérre Siè, Normand Blais, Isabelle Gouin‐Thibault, Sophie Susen

Research and Practice in Thrombosis and Haemostasis20256 citationsOpen Access

DOI: 10.1016/j.rpth.2025.102860 PMID: 40496572

Clinical Utility of Liquid Biopsy for the Early Diagnosis of EGFR-Mutant Advanced Lung Cancer Patients in a Real-Life Setting (CLEAR Study).

Samaha R, El Sayed R, Alameddine R, Florescu M, Tehfe M, Routy B, Elkrief A, Belkaid W, Desilets A, Weng X, Nassabein R, Blanc-Durand F, Kenth G, Kasymjanova G, Agulnik J, Blais N

Current oncology (Toronto, Ont.)20255 citationsSenior authorOpen Access

DOI: 10.3390/curroncol32020057 PMID: 39996857

A population-based analysis of patterns of care in patients with high-risk non-muscle-invasive bladder cancer from Alberta, Canada

Gotto G, Alimohamed NS, Kulkarni GS, Black PC, Kassouf W, Kokorovic A, Eigl BJ, Blais N, Lalani A-KA, Cheung WY

Journal of the Canadian Urological Association20252 citationsOpen Access

DOI: 10.5489/cuaj.9110

Canadian Perspectives Revisited: Consensus on the management of ALK-rearranged NSCLC

Melosky B, Chu QSC, Juergens RA, Snow S, Blais N, Cheema P, Sangha R, Agulnik J, Martins I, Burkes RL

Lung Cancer20252 citations

DOI: 10.1016/j.lungcan.2025.108717

A population-based analysis of patterns of care in patients with de novo muscle-invasive bladder cancer from Alberta, Canada

Alimohamed NS, Gotto G, Kulkarni GS, Black PC, Kassouf W, Sridhar SS, Kokorovic A, Eigl BJ, Blais N, Lalani A-KA

Journal of the Canadian Urological Association2025Open Access

DOI: 10.5489/cuaj.9111

Novel Approach to Proficiency Testing Reveals Significant Variations in Biomarker Practice Leading to Critical Differences in Lung Cancer Management.

Bisson KR, Beharry A, Blais N, Carter MD, Cheema PK, Desmeules P, Garratt JG, Melosky B, Lo B, Snow S, Tessier-Cloutier B, Tio E, Yip S, Won JR, Sheffield BS

JTO clinical and research reports2025Open Access

DOI: 10.1016/j.jtocrr.2025.100837 PMID: 40567262

Recurrent chronic conjunctival erosions secondary to cabozantanib.

Youhnovska E, Pollmann AS, Blais N, Robert MC

Canadian journal of ophthalmology. Journal canadien d'ophtalmologie2025

DOI: 10.1016/j.jcjo.2024.11.002 PMID: 39592093

Profile data last refreshed on September 29, 2026 from the university directory, publication records and public research funding records.

Something wrong or missing on this profile? Suggest a correction

Normand Blais

Research

Latest papers

Targeting common EGFR mutations in non–small cell lung cancer: a review of global phase 3 trials of third-generation inhibitors

Neoadjuvant Chemotherapy-Immunotherapy in Non-Small Cell Lung Cancer: Can Positron Emission Tomography Scan Predict Complete Pathologic Response?

Consensus recommendations on surveillance and survivorship for patients with unresectable/stage IV non-small cell lung cancer after completing Immunotherapy: a Delphi study by Canadian experts

Management of bleeding and invasive procedures in patients treated with anti–factor XI(a) anticoagulants: proposals from the French Working Group on Perioperative Haemostasis and French Society of Thrombosis and Haemostasis

Clinical Utility of Liquid Biopsy for the Early Diagnosis of EGFR-Mutant Advanced Lung Cancer Patients in a Real-Life Setting (CLEAR Study).

A population-based analysis of patterns of care in patients with high-risk non-muscle-invasive bladder cancer from Alberta, Canada

Canadian Perspectives Revisited: Consensus on the management of ALK-rearranged NSCLC

A population-based analysis of patterns of care in patients with de novo muscle-invasive bladder cancer from Alberta, Canada

Novel Approach to Proficiency Testing Reveals Significant Variations in Biomarker Practice Leading to Critical Differences in Lung Cancer Management.

Recurrent chronic conjunctival erosions secondary to cabozantanib.

Frequent collaborators

Bertrand Routy

Mustapha Tehfe

Srikala Sridhar

Wassim Kassouf

Rosalyn Juergens

Paul Wheatley-Price

Shantanu Banerji

Girish Kulkarni

Geoffrey Liu

Lesley Seymour

Ming-Sound Tsao

Arielle Elkrief

Danh Tran-Thanh

Adrian Sacher

Bernhard Eigl

Ming Tsao

John Goffin

Christina Canil

Alan So

Dongsheng Tu

Sebastien Hotte

Mark Vincent

Martine Montigny

Jean-Pierre Ayoub

David Roberge

Lyne Lalonde

Marie-Claude Vanier

Mussawar Iqbal

Guila Delouya

Charles Leduc

Élie Kassouf

Philippe Stephenson

Roula Albadine

Francine Aubin

Jean-Paul Bahary

Chantal Pharand

Alex Bourguignon

Nayyer Iqbal

Razvan Diaconescu

Kévin Jao